Since the 1970s, our society has been undergoing rapid digitalization. This has been paralleled by rapid advancements in biology, in particular with the sequencing of the human genome and the development of proteomics and metabolomics. This digital world presents an unmatched opportunity to revolutionize health. Today, genetic medicines deal with patients who have inherited diseases. Tomorrow, we will be able to deal with a much larger scope, including the multigenic susceptibility to disease. This is the promise of precision medicine. Cancer is a major focus of precision medicine. Initiative and developments in precise and effective treatment could benefit many other chronic diseases. Precision oncology focuses on matching the most accurate and effective treatment to this individual cancer patient based on the genetic profile of cancer and the individual,(Precision Medicine the Foundation of Future Cancer Therapeutics - Google Search, n.d.). Because every single cancer patient exhibits a different genetic profile. It can help make more accurate diagnosis and improve treatment that can help people to make decisions regarding their own health and they can deal with areas of uncertainty that might have lowered their risk of cancer.